Acute and late GI toxicity (grade 2+) · People undergoing pelvic radiotherapy for urological, gynaecological or colorectal cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diarrhoea (grade 2+) · People undergoing pelvic radiotherapy for urological, gynaecological or colorectal cancer
Summary of findings: Diet interventions showed no clear difference in diarrhoea (grade 2+) compared with usual on‐treatment diet (low certainty).
1 finding from 1 review
QoL · People undergoing pelvic radiotherapy for urological, gynaecological or colorectal cancer
Summary of findings: Diet interventions showed no clear difference in QOL scores (IBDQ) (higher scores better) compared with usual on‐treatment diet (low certainty).
3 findings from 1 review
MD 4.6
1 study · 50 participants
Low
no estimate extracted
1 study · 119 participants
GRADE not reported
MD 2.4
1 study · 76 participants
Low
Lactose‐restricted diet · People undergoing pelvic radiotherapy for urological, gynaecological or colorectal cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diarrhoea (grade 1+) · People undergoing pelvic radiotherapy for urological, gynaecological or colorectal cancer
Summary of findings: Diet interventions showed no clear difference in diarrhoea (grade 1+) compared with usual on‐treatment diet (low certainty).
1 finding from 1 review
High‐fibre diet · People undergoing pelvic radiotherapy for urological, gynaecological or colorectal cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Low‐fibre diet · People undergoing pelvic radiotherapy for urological, gynaecological or colorectal cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Low‐fat diet · People undergoing pelvic radiotherapy for urological, gynaecological or colorectal cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean GI symptom scores (Vaizey scale) (higher scores better) · People undergoing pelvic radiotherapy for urological, gynaecological or colorectal cancer
Summary of findings: Diet interventions showed no clear difference in mean GI symptom scores (Vaizey scale) (higher scores better) compared with usual on‐treatment diet (low certainty).
1 finding from 1 review
Diarrhoea · People undergoing pelvic radiotherapy for urological, gynaecological or colorectal cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Prebiotic diet · People undergoing pelvic radiotherapy for urological, gynaecological or colorectal cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Repetition of SH at 12 months · adults who engage in SH
It is very uncertain whether comparison 7: Other mixed interventions changes repetition of SH at 12 months compared with treatment (very low certainty).
1 finding from 1 review
Repetition of SH at final · adults who engage in SH
Comparison 7: Other mixed interventions showed no clear difference in repetition of SH at final compared with treatment (low certainty).
7 findings from 1 review
OR 1.02 [0.71, 1.47]
1 study · 1663 participants
Low
OR 2.27 [0.97, 5.28]
1 study · 135 participants
Very low
OR 0.55 [0.13, 2.34]
1 study · 251 participants
Very low
Show 4 more findings
OR 1.18 [0.69, 2]
1 study · 601 participants
Low
OR 2.01 [0.08, 50.6]
1 study · 96 participants
Very low
OR 0.39 [0.17, 0.92]
1 study · 561 participants
Low
OR 0.65 [0.15, 2.85]
2 studies · 245 participants
Very low
Frequency of SH at final · adults who engage in SH
1 finding from 1 review
Repetition of SH at 6 months' · adults who engage in SH
Comparison 7: Other mixed interventions showed no clear difference in repetition of SH at 6 months compared with treatment (low certainty).
2 findings from 1 review
Frequency of SH at 12 months · adults who engage in SH
1 finding from 1 review
Repetition of SH at 24 months · adults who engage in SH
Comparison 7: Other mixed interventions showed no clear difference in repetition of SH at 24 months compared with treatment (low certainty).
1 finding from 1 review
Patient outcomes (continuous) · Healthcare professionals
1 finding from 1 review
Resource use · Healthcare professionals
1 finding from 1 review
Adverse effects · Healthcare professionals
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found